-
Tetraphase's Stock Just Lost 80%, You Should Flush It...Right?
Wednesday, September 9, 2015 - 2:22pm | 780Read More...Shares of Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) plunged nearly 80 percent on Wednesday, trading as low as $9.00 per share. The massive selloff is attributed to the company failing to meet the primary endpoint of statistical non-inferiority for IGNITE2 compared to levofloxacin. Here is a...
-
Is Tetraphase Pharmaceuticals A Buyout Candidate? Brean Capital Thinks So
Friday, March 6, 2015 - 11:46am | 215Read More...In a report published Friday, Brean Capital analyst Jonathan Aschoff said that that Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) is a "prime takeout candidate" as the company continues to target NDA submission for eravacycline for both indications (cUTI and cIAI) by the end of 2015...
